Catalent expands packaging capabilities in Singapore
PTSM: Pharmaceutical Technology Sourcing and Management
Catalent’s Singapore facility is awarded GMP certification.
Catalent announced on June 16 that it has expanded its Singapore facility to provide secondary packaging and labeling capabilities. The site, which recently received GMP approval from the Health Science Authority, is now approved for GMP across all its activities, including secondary packaging, label printing, storage, distribution, returns and destruction management.
Catalent offers clinical supply systems and facilities in the United States, United Kingdom, Germany, Singapore and China, and a network of more than 60 audited depots. The company reports that it can handle a range of international compliance and distribution requirements, and reduce customer turnaround time.
Source: Catalent
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
